Knight Initiative News

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease, but which also carry safety risks according to Knight Initiative for Brain Resilience affiliate Mike Greicius and others.

Experts at Stanford Medicine Children’s Health helped conduct clinical trials for the new therapy, which gives kids with X-linked adrenoleukodystrophy, or ALD, a functioning copy of the abnormal gene.

To advance neuroscience research using EEG and TMS technologies, the Koret Human Neurosciences Community Lab has awarded its inaugural Human Neuroscience Pilot Grants to ten innovative research projects.

This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain.

Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.

This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine.

The recent discovery that intestinal neurons normally self-organize into a striped pattern around the time of birth could help explain wide-ranging GI disorders in children, say Wu Tsai Neuro Faculty Scholar Julia Kaltschmidt and her team.

Pro-inflammatory protein TREM1 in peripheral immune cells may promote age-related cognitive decline and dementia, according to Knight Initiative–funded research.

Recent research supported by the Knight Initiative has identified a link between lipid droplets in the microglia to a known genetic risk factor for AD.

This week, I join my producer Michael Osborne on his podcast, Famous and Gravy, to discuss the late, great neuroscientist and author Oliver Sacks.

This week, we sit down with neuroscientist Tony Wyss-Coray to learn about how some of your organs may be aging faster than the rest of you.

This week on From Our Neurons to Yours, we sit down with Stanford neurologist Kathleen Poston to learn about a sea change in our understanding of Parkinson's Disease.

Disabling the notorious APOE4 gene might protect against the disease, according to research from Michael Greicius and team.

This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time.

The Wu Tsai Neurosciences Institute’s sixth round of Neuroscience:Translate awards aim to accelerate promising discoveries from the lab to patient impact.

This week we talk with Jaimie Henderson, a Stanford neurosurgeon leading groundbreaking research in brain-machine interfaces.

We are proud to welcome the 2024 Neurosciences Postdoctoral Scholars — ten young scientists pursuing novel, multi-disciplinary approaches to understanding the workings of the brain.

The science to advance our understanding of the aging process—and to potentially slow it down—has made important strides. One of the leading scientists responsible for this work is Professor Tony Wyss-Coray, whose work has focused on brain aging.

The Wu Tsai Neurosciences Institute at Stanford University is proud to announce the recipients of its fifth round of Seed Grants.

This week, we dive into this misunderstood and often stigmatized world of epilepsy with Stanford neurologist Fiona Baumer.